imiquimod has been researched along with Precancerous Conditions in 47 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 25 (53.19) | 29.6817 |
| 2010's | 19 (40.43) | 24.3611 |
| 2020's | 3 (6.38) | 2.80 |
| Authors | Studies |
|---|---|
| Alonso-Martinez de Salinas, L; Azcarraga-Llobet, C; Bea-Ardebol, S; Berna-Rico, E; de Nicolas-Ruanes, B; Garcia-Mouronte, E | 1 |
| Cornacchia, L; Lai, M; Longo, C; Pampena, R; Pellacani, G; Peris, K | 1 |
| Linares-Gonzalez, L; Navarro-Triviño, FJ; Ródenas-Herranz, T; Ruiz-Villaverde, R | 1 |
| Meinert, M; Vorbeck, CS; Østergård, S | 1 |
| Calzavara-Pinton, P; Hamon, P; Tanova, N | 1 |
| Cockerell, CJ; Samrao, A | 1 |
| Champagne, BJ; Crawshaw, BP; Delaney, CP; Marderstein, EL; Reynolds, HL; Russ, AJ; Stein, SL | 1 |
| Isoherranen, K; Koskenmies, S; Overmark, M; Pitkänen, S; Saksela, O; Ylitalo, L | 1 |
| Arnold, P; Gogoll, K; Langguth, P; Lee, KD; Peters, T; Radsak, M; Schild, H; Stein, P | 1 |
| Cowen, PS; Gebauer, K; Shumack, S | 1 |
| Adam, F; Fenske, NA; Spencer, J | 1 |
| Kerl, H; Kopera, D | 1 |
| Chrisovergis, A; Eleftheriadou, A; Ferekidou, E; Gkoulioni, V; Kandiloros, D; Lazaris, ACh; Yiotakis, I | 1 |
| Braga, JC; Busam, K; Dusza, SW; Gill, M; Halpern, AC; Marghoob, AA; Scope, A; Terushkin, V | 1 |
| Doherty, SD; Rosen, T; Shah, AY | 1 |
| LeLeux, TM; Orengo, I; Rosen, T; Venkatarajan, S; Yang, D | 1 |
| Badger, J; Dadras, SS; Kong, CS; Taube, JM | 1 |
| Jadotte, YT; Schwartz, RA | 1 |
| Gormley, RH; Kovarik, CL | 1 |
| Fox, PA | 1 |
| Esmann, S; Jemec, GB | 1 |
| Balaguer, A; Barberà, MJ; Macaya, A; Muñoz-Santos, C | 1 |
| Hruza, G | 1 |
| Caglar, S; Crespo, J; Saini, R; Tutrone, WD; Weinberg, JM | 1 |
| Hengge, UR; Meykadeh, N | 1 |
| Alam, M; Goldberg, LH; Silapunt, S | 1 |
| Huntley, A; Navi, D | 1 |
| Berville-Levy, S; Bourgault-Villada, I; Clerici, T; Moyal-Barracco, M; Saiag, P; Wendling, J | 1 |
| Fein, H; McGillis, ST | 1 |
| Arenberger, P; Benninghoff, B; Hengge, UR; Lysa, B; Ruzicka, T; Tartler, U; Walz, M; Wolf, R | 1 |
| Korman, N; Lee, JH; Ling, M; Matheson, R; McKane, S; Moy, R; Smith, S | 1 |
| Hengge, UR; Schaller, J | 1 |
| Atkins, CL; Brown, VL; Cerio, R; Ghali, L; Harwood, CA; Proby, CM | 1 |
| Altmeyer, P; Markus, S; Oster-Schmidt, C | 1 |
| Boonchai, W | 1 |
| Cruickshank, DJ; Lonsdale-Eccles, AA; Morgan, JM; Nagarajan, S | 1 |
| Dissemond, J; Grabbe, S | 1 |
| Busch, JO; Meyer, T; Nindl, I; Schmook, T; Sterry, W; Stockfleth, E; Ulrich, C | 1 |
| Claessen, SM; Creytens, DH; Lucker, GP; Meulemans, EV; Pauwels, P; Peeters, JH; Speel, EJ; van Geest, AJ; Vermeulen, AH | 1 |
| Bruchim, I; Ferenczy, A; Gotlieb, WH; Grzywacz, K; Mahmud, S; Tunitsky, E | 1 |
| Altmeyer, P; Brockmeyer, NH; Gambichler, T; Kreuter, A; Pfister, H; Potthoff, A; Racz, P; Tenner-Racz, K; Wieland, U | 1 |
| Falagas, ME; Papadavid, E; Stratigos, AJ | 1 |
| Athanasiou, S; Falagas, ME; Iavazzo, C; Pitsouni, E | 1 |
| Benninghoff, B; Christophers, E; Meyer, T; Stockfleth, E | 1 |
| Hengge, UR; Stark, R | 1 |
| Etherington, IJ; Luesley, DM; Todd, RW | 1 |
20 review(s) available for imiquimod and Precancerous Conditions
| Article | Year |
|---|---|
Imiquimod as Local Immunotherapy in the Management of Premalignant Cutaneous Conditions and Skin Cancer.
Topics: Adjuvants, Immunologic; Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Humans; Imiquimod; Immunotherapy; Precancerous Conditions; Skin; Skin Neoplasms | 2023 |
Treatments of actinic cheilitis: A systematic review of the literature.
Topics: Aminolevulinic Acid; Carcinoma, Squamous Cell; Cheilitis; Combined Modality Therapy; Dermabrasion; Diclofenac; Disease Progression; Fluorouracil; Humans; Imiquimod; Laser Therapy; Lip Neoplasms; Photochemotherapy; Precancerous Conditions; Treatment Outcome | 2020 |
Successful treatment of micaceous balanitis with 5% topical imiquimod: case report and review of the literature.
Topics: Administration, Topical; Adult; Balanitis; Carcinoma, Squamous Cell; Disease Progression; Humans; Imiquimod; Male; Penile Neoplasms; Precancerous Conditions; Treatment Outcome | 2020 |
[Vulvar intraepithelial neoplasia].
Topics: Antineoplastic Agents; Carcinoma in Situ; Female; Humans; Imiquimod; Immunocompromised Host; Papillomaviridae; Papillomavirus Infections; Papillomavirus Vaccines; Precancerous Conditions; Vulvar Neoplasms | 2018 |
Pharmacotherapeutic management of actinic keratosis: focus on newer topical agents.
Topics: Administration, Topical; Aminoquinolines; Cryotherapy; Diclofenac; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluorouracil; Follow-Up Studies; Humans; Imiquimod; Keratosis, Actinic; Male; Photochemotherapy; Precancerous Conditions; Severity of Illness Index; Treatment Outcome | 2013 |
[Diagnosis and treatment of actinic keratosis].
Topics: Administration, Topical; Aminoquinolines; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Cryotherapy; Diclofenac; Diterpenes; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Laser Therapy; Photochemotherapy; Precancerous Conditions; Primary Health Care | 2015 |
Actinic keratoses: past, present and future.
Topics: Adjuvants, Immunologic; Aminoquinolines; Anti-Inflammatory Agents, Non-Steroidal; Carcinoma, Squamous Cell; Cryosurgery; Diclofenac; Fluorouracil; Humans; Imiquimod; Immunosuppressive Agents; Keratosis, Actinic; Photochemotherapy; Precancerous Conditions; Skin Neoplasms | 2010 |
Actinic cheilitis: a treatment review.
Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Caustics; Cheilitis; Cryosurgery; Electrocoagulation; Fluorouracil; Humans; Imiquimod; Laser Therapy; Lip; Photochemotherapy; Precancerous Conditions; Risk Factors; Skin Neoplasms; Trichloroacetic Acid | 2010 |
Differentiated (simplex) vulvar intraepithelial neoplasia: a case report and review of the literature.
Topics: Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Female; Humans; Imiquimod; Lichen Sclerosus et Atrophicus; Precancerous Conditions; Vulvar Neoplasms | 2011 |
Human papillomavirus-related genital disease in the immunocompromised host: Part II.
Topics: Adjuvants, Immunologic; Alphapapillomavirus; Aminoquinolines; Antineoplastic Agents, Phytogenic; Antiviral Agents; Anus Neoplasms; Buschke-Lowenstein Tumor; Catechin; Caustics; Cidofovir; Condylomata Acuminata; Counseling; Cryotherapy; Cytosine; Female; Humans; Imiquimod; Immunocompromised Host; Male; Ointments; Organophosphonates; Papillomavirus Infections; Penile Neoplasms; Podophyllotoxin; Precancerous Conditions; Treatment Outcome; Trichloroacetic Acid; Vaginal Neoplasms; Vulvar Neoplasms; Warts | 2012 |
Treatment options for anal intraepithelial neoplasia and evidence for their effectiveness.
Topics: Adult; Aminoquinolines; Antimetabolites, Antineoplastic; Antineoplastic Agents; Anus Neoplasms; Cidofovir; Comorbidity; Cytosine; Female; Fluorouracil; Global Health; HIV Infections; Homosexuality, Male; Humans; Imiquimod; Incidence; Male; Organophosphonates; Papillomavirus Infections; Precancerous Conditions; Trichloroacetic Acid | 2012 |
Interventions for anal canal intraepithelial neoplasia.
Topics: Aminoquinolines; Anal Canal; Antineoplastic Agents; Anus Neoplasms; Carcinoma in Situ; Humans; Imiquimod; Precancerous Conditions; Randomized Controlled Trials as Topic | 2012 |
Topical therapy for actinic keratoses, I: 5-Fluorouracil and imiquimod.
Topics: Administration, Cutaneous; Aminoquinolines; Antimetabolites, Antineoplastic; Antineoplastic Agents; Fluorouracil; Humans; Imiquimod; Keratosis; Precancerous Conditions; Randomized Controlled Trials as Topic; Skin Neoplasms | 2003 |
Topical and light-based treatments for actinic keratoses.
Topics: Adjuvants, Immunologic; Administration, Topical; Aminolevulinic Acid; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Cyclooxygenase Inhibitors; Diclofenac; Fluorouracil; Humans; Hyaluronic Acid; Imiquimod; Keratosis; Photochemotherapy; Photosensitivity Disorders; Photosensitizing Agents; Precancerous Conditions; Retinoids; Skin Neoplasms; Vitamin A | 2003 |
Imiquimod 5 percent cream and the treatment of cutaneous malignancy.
Topics: Aminoquinolines; Antineoplastic Agents; Apoptosis; Bowen's Disease; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cell Line, Tumor; Clinical Trials as Topic; Condylomata Acuminata; Drug Screening Assays, Antitumor; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Immunity, Cellular; Immunologic Factors; Keratoacanthoma; Keratosis; Male; Melanoma; Multicenter Studies as Topic; Mycosis Fungoides; Ointments; Paget Disease, Extramammary; Precancerous Conditions; Randomized Controlled Trials as Topic; Skin Neoplasms | 2004 |
Topical treatment strategies for non-melanoma skin cancer and precursor lesions.
Topics: Administration, Topical; Aminoquinolines; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Carcinoma, Basal Cell; Diclofenac; Fluorouracil; Humans; Imiquimod; Keratosis; Photochemotherapy; Precancerous Conditions; Skin Neoplasms; Sunlight | 2004 |
[Solar keratosis: from precancerous lesion to pre-invasive squamous cell carcinoma--therapeutic approach with a bioinductive method].
Topics: Adjuvants, Immunologic; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Diagnosis, Differential; Disease Progression; Female; Follow-Up Studies; Humans; Imiquimod; Interferon Inducers; Keratosis; Male; Middle Aged; Ointments; Precancerous Conditions; Prospective Studies; Skin Neoplasms; Time Factors; Treatment Outcome; Ultraviolet Rays | 2003 |
[Actinic keratosis].
Topics: Adjuvants, Immunologic; Age Factors; Aged; Aminoquinolines; Antimetabolites, Antineoplastic; Antineoplastic Agents; Carcinoma, Squamous Cell; Cryotherapy; Diagnosis, Differential; Female; Fluorouracil; Humans; Imiquimod; Interferon Inducers; Keratosis; Laser Therapy; Male; Ointments; Photochemotherapy; Precancerous Conditions; Risk Factors; Skin Neoplasms; Time Factors; Ultraviolet Rays | 2006 |
Imiquimod: an immune response modifier in the treatment of precancerous skin lesions and skin cancer.
Topics: Adjuvants, Immunologic; Aminoquinolines; Animals; Carcinoma, Basal Cell; Humans; Imiquimod; Photosensitivity Disorders; Precancerous Conditions; Skin Diseases; Skin Neoplasms | 2007 |
Imiquimod for treatment of vulvar and vaginal intraepithelial neoplasia.
Topics: Administration, Cutaneous; Administration, Intravaginal; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Female; Humans; Imiquimod; Precancerous Conditions; Treatment Outcome; Vaginal Neoplasms; Vulvar Neoplasms | 2008 |
6 trial(s) available for imiquimod and Precancerous Conditions
| Article | Year |
|---|---|
Effect of dosing frequency on the safety and efficacy of imiquimod 5% cream for treatment of actinic keratosis on the forearms and hands: a phase II, randomized placebo-controlled trial.
Topics: Adjuvants, Immunologic; Administration, Cutaneous; Aged; Aminoquinolines; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Forearm; Hand Dermatoses; Humans; Imiquimod; Keratosis, Actinic; Male; Precancerous Conditions; Treatment Outcome | 2009 |
Treatment of undifferentiated vulvar intraepithelial neoplasia with 5% imiquimod cream: a prospective study of 12 cases.
Topics: Administration, Cutaneous; Adult; Aminoquinolines; Antineoplastic Agents; Female; Humans; Imiquimod; Middle Aged; Papillomaviridae; Precancerous Conditions; Prospective Studies; Treatment Outcome; Vulvar Neoplasms | 2004 |
Dosing with 5% imiquimod cream 3 times per week for the treatment of actinic keratosis: results of two phase 3, randomized, double-blind, parallel-group, vehicle-controlled trials.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Aminoquinolines; Confidence Intervals; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Imiquimod; Keratosis; Male; Middle Aged; Ointments; Precancerous Conditions; Probability; Reference Values; Risk Assessment; Severity of Illness Index; Skin Neoplasms; Statistics, Nonparametric; Treatment Outcome | 2005 |
Safety and efficacy of 5% imiquimod cream for the treatment of skin dysplasia in high-risk renal transplant recipients: randomized, double-blind, placebo-controlled trial.
Topics: Acitretin; Adjuvants, Immunologic; Administration, Topical; Adult; Aged; Aminoquinolines; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Double-Blind Method; Female; Humans; Imiquimod; Immunosuppression Therapy; Keratolytic Agents; Kidney Transplantation; Male; Middle Aged; Ointments; Precancerous Conditions; Risk Factors; Skin; Skin Neoplasms | 2005 |
Successful treatment of multiple actinic keratoses in organ transplant patients with topical 5% imiquimod: a report of six cases.
Topics: Administration, Cutaneous; Aged; Aminoquinolines; Drug Administration Schedule; Humans; Imiquimod; Immunocompromised Host; Immunologic Factors; Keratosis; Male; Middle Aged; Photosensitivity Disorders; Pilot Projects; Precancerous Conditions; Skin Neoplasms; Transplants; Treatment Outcome | 2006 |
The effects of 5% imiquimod cream on high-grade vulval intraepithelial neoplasia.
Topics: Administration, Topical; Adult; Aminoquinolines; Antineoplastic Agents; Female; Humans; Imiquimod; Middle Aged; Ointments; Precancerous Conditions; Prospective Studies; Vulvar Neoplasms | 2002 |
21 other study(ies) available for imiquimod and Precancerous Conditions
| Article | Year |
|---|---|
Evaluation of the treatment costs and duration of topical treatments for multiple actinic keratosis based on the area of the cancerization field and not on the number of lesions.
Topics: Administration, Topical; Aminolevulinic Acid; Cohort Studies; Cost of Illness; Diclofenac; Diterpenes; Drug Administration Schedule; Female; Fluorouracil; Health Care Costs; Humans; Imiquimod; Italy; Keratosis, Actinic; Male; Photochemotherapy; Precancerous Conditions; Retrospective Studies; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2019 |
High-resolution anoscopy or expectant management for anal intraepithelial neoplasia for the prevention of anal cancer: is there really a difference?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Anus Diseases; Anus Neoplasms; Biopsy; Combined Modality Therapy; Female; Humans; Imiquimod; Male; Middle Aged; Precancerous Conditions; Proctoscopy; Retrospective Studies; Treatment Outcome | 2015 |
Solid nanoemulsion as antigen and immunopotentiator carrier for transcutaneous immunization.
Topics: Adjuvants, Immunologic; Administration, Cutaneous; Aminoquinolines; Animals; Antineoplastic Agents; Chemistry, Pharmaceutical; Drug Delivery Systems; Humans; Imiquimod; Immunization; Langerhans Cells; Mice; Mice, Inbred C57BL; Nanostructures; Oils; Precancerous Conditions; Skin Neoplasms; Vaccination | 2016 |
Detection and treatment of preclinical actinic keratoses (PAK).
Topics: Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Carcinoma, Squamous Cell; Facial Dermatoses; Female; Humans; Imiquimod; Keratosis, Actinic; Middle Aged; Neoplasms, Radiation-Induced; Precancerous Conditions; Skin Aging | 2010 |
Vulvar cancer. Skin changes not to be ignored.
Topics: Administration, Topical; Age Factors; Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Female; Humans; Imiquimod; Laser Therapy; Middle Aged; Precancerous Conditions; Risk Factors; Vulvar Neoplasms | 2010 |
The efficacy of imiquimod on dysplastic lesions of the oral mucosa: an experimental model.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Aminoquinolines; Animals; Antineoplastic Agents; Carcinogens; Carcinoma, Squamous Cell; Imiquimod; Male; Mouth Mucosa; Mouth Neoplasms; Precancerous Conditions; Rats; Rats, Wistar | 2010 |
Agreement on the clinical diagnosis and management of cutaneous squamous neoplasms.
Topics: Algorithms; Aminoquinolines; Biopsy; Carcinoma in Situ; Carcinoma, Squamous Cell; Cryosurgery; Curettage; Dermatology; Diagnosis, Differential; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Mohs Surgery; Photochemotherapy; Precancerous Conditions; Reproducibility of Results; Skin Neoplasms; Terminology as Topic; United States | 2010 |
Porokeratosis of Mibelli: Successful treatment with 5 percent topical imiquimod and topical 5 percent 5-fluorouracil.
Topics: Administration, Cutaneous; Aged, 80 and over; Aminoquinolines; Antimetabolites; Carcinoma, Basal Cell; Fluorouracil; Humans; Imiquimod; Immunologic Factors; Leg; Male; Porokeratosis; Precancerous Conditions; Remission Induction; Skin Neoplasms | 2010 |
Solar cheilosis: an ominous precursor part II. Therapeutic perspectives.
Topics: Administration, Topical; Aminoquinolines; Biopsy; Carcinoma, Squamous Cell; Cheilitis; Combined Modality Therapy; Diagnosis, Differential; Diclofenac; Female; Fluorouracil; Humans; Imiquimod; Lip Neoplasms; Male; Middle Aged; Precancerous Conditions; Skin Neoplasms; Sunlight | 2012 |
Patients' perceptions of topical treatments of actinic keratosis.
Topics: Administration, Topical; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Diclofenac; Female; Fluorouracil; Gels; Humans; Imiquimod; Keratosis, Actinic; Male; Middle Aged; Patient Acceptance of Health Care; Photochemotherapy; Precancerous Conditions; Skin Cream | 2014 |
Catching skin cancer early. New treatments aim to keep keratoses from developing into invasive cancer.
Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Cryotherapy; Humans; Imiquimod; Keratosis; Photochemotherapy; Precancerous Conditions; Risk Factors; Skin Neoplasms | 2002 |
[Topical immunomodulators in dermatology].
Topics: Adjuvants, Immunologic; Administration, Topical; Adult; Aged; Aged, 80 and over; Aminoquinolines; Asthma; Autoimmune Diseases; Bowen's Disease; Child; Cyclopropanes; Dermatitis, Atopic; Dinitrochlorobenzene; Female; Follow-Up Studies; Herpes Simplex; Humans; Imidazoles; Imiquimod; Immunity, Cellular; Immunocompromised Host; Immunoglobulin A; Immunosuppressive Agents; Lichen Sclerosus et Atrophicus; Male; Molluscum Contagiosum; Papillomavirus Infections; Precancerous Conditions; Skin Diseases; Skin Diseases, Viral; Skin Neoplasms; Tacrolimus; Time Factors; Warts | 2003 |
Gene expression in actinic keratoses: pharmacological modulation by imiquimod.
Topics: Aged; Aminoquinolines; Antineoplastic Agents; Apoptosis; Cell Adhesion Molecules; Cytokines; Gene Expression Regulation; Genes, p53; Humans; Imiquimod; Interferon Inducers; Keratosis; Male; Membrane Glycoproteins; Middle Aged; Neoplasms, Radiation-Induced; Precancerous Conditions; Receptors, Cell Surface; Reverse Transcriptase Polymerase Chain Reaction; Skin Neoplasms; Toll-Like Receptor 7; Toll-Like Receptor 8; Toll-Like Receptors | 2004 |
Imiquimod and squamous cell cancer.
Topics: Aminoquinolines; Biopsy, Needle; Bowen's Disease; Carcinoma, Squamous Cell; Follow-Up Studies; Humans; Imiquimod; Immunohistochemistry; Precancerous Conditions; Risk Assessment; Skin Neoplasms; Treatment Outcome | 2005 |
Treatment of precancerous and cancerous lesions of chronic arsenicism with 5% imiquimod cream.
Topics: Administration, Cutaneous; Aged; Aminoquinolines; Antineoplastic Agents; Arsenic; Arsenic Poisoning; Chronic Disease; Forearm; Humans; Imiquimod; Keratosis; Male; Precancerous Conditions; Skin Neoplasms; Water Pollutants, Chemical | 2006 |
Successful treatment of vulval melanoma in situ with topical 5% imiquimod cream.
Topics: Aged; Aminoquinolines; Antineoplastic Agents; Female; Humans; Imiquimod; Melanoma; Precancerous Conditions; Vulvar Neoplasms | 2006 |
Differences in imiquimod treatment outcome in two patients with bowenoid papulosis containing either episomal or integrated human papillomavirus 16.
Topics: Adjuvants, Immunologic; Adult; Aged; Aminoquinolines; Human papillomavirus 16; Humans; Imiquimod; In Situ Hybridization; In Situ Hybridization, Fluorescence; Male; Penile Diseases; Plasmids; Precancerous Conditions; Treatment Outcome | 2007 |
HPV-related vulvar intraepithelial neoplasia: outcome of different management modalities.
Topics: Adjuvants, Immunologic; Adult; Aged; Aminoquinolines; Carcinoma in Situ; Catheter Ablation; Female; Follow-Up Studies; Humans; Imiquimod; Laser Therapy; Middle Aged; Papillomavirus Infections; Precancerous Conditions; Retrospective Studies; Treatment Outcome; Vulvar Neoplasms | 2007 |
p16ink4a expression decreases during imiquimod treatment of anal intraepithelial neoplasia in human immunodeficiency virus-infected men and correlates with the decline of lesional high-risk human papillomavirus DNA load.
Topics: Administration, Cutaneous; Adult; AIDS-Related Opportunistic Infections; Aminoquinolines; Antineoplastic Agents; Anus Neoplasms; Biomarkers, Tumor; Carcinoma in Situ; Cyclin-Dependent Kinase Inhibitor p16; DNA, Viral; Homosexuality, Male; Humans; Imiquimod; Ki-67 Antigen; Male; Papillomaviridae; Papillomavirus Infections; Pilot Projects; Precancerous Conditions; Viral Load | 2007 |
Successful treatment of actinic keratosis with imiquimod cream 5%: a report of six cases.
Topics: Administration, Cutaneous; Aged; Aminoquinolines; Antineoplastic Agents; Drug Administration Schedule; Follow-Up Studies; Humans; Imiquimod; Keratosis; Male; Middle Aged; Neoplasms, Radiation-Induced; Precancerous Conditions; Recurrence; Scalp Dermatoses; Skin Neoplasms | 2001 |
Topical imiquimod to treat intraepidermal carcinoma.
Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Carcinoma, Squamous Cell; Female; Humans; Imiquimod; Keratosis; Male; Middle Aged; Nose; Photosensitivity Disorders; Precancerous Conditions; Skin Neoplasms; Thorax | 2001 |